Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Por um escritor misterioso

Descrição

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Molecules, Free Full-Text
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Challenges and opportunities in targeting the menin-MLL interaction.
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Biomedicines, Free Full-Text
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia - ScienceDirect
de por adulto (o preço varia de acordo com o tamanho do grupo)